Clinical Pharmacology Lead, Senior Manager

CRISPR Therapeutics, Inc.; Boston (MA); Hybrid; USD 135,000 - 150,000; Full time

Benefits offered by this job

Remote work flexibility

On-site collaboration

Job summary

CRISPR Therapeutics, Inc. in Boston, MA seeks a Clinical Pharmacology Lead to shape strategy from IND through late-stage development for novel gene therapies.

You will own pharmacology plans, drive dose justification, and collaborate across discovery, clinical operations, and regulatory teams. The ideal candidate has 10+ years in clinical pharmacology, expertise in PK/PD modeling, and a strong regulatory mindset.

Qualifications

• BS in pharmacology, pharmaceutical sciences, pharmacometrics, biomedical engineering, or related field with 10+ years of industry clinical pharmacology experience.
• Hands-on proficiency with NCA (e.g., Phoenix WinNonlin) and population modeling approaches (e.g., NONMEM, Monolix, R).
• Working knowledge of bioanalytical techniques, assay development and validation.
• Excellent oral and written communication skills.
• Ability to travel up to 10%.

Responsibilities

• Serve as the clinical pharmacology lead on cross‑functional program teams, owning strategy from IND through later-stage development.
• Drive dose selection by integrating nonclinical and clinical data, including first-in-human dosing and escalation.
• Design PK/PD and biomarker sampling strategies for clinical protocols with cross-functional partners.
• Collaborate with operations to inform sample journey plans and lab manuals.
• Translate program needs into clinical assays and vendor strategies.
• Manage CROs and vendors for assay development, transfer, validation, and data analysis.
• Monitor GLP/GCLP validation at CROs and ensure timely document reviews.
• Ensure assay validation and analyses meet regulatory standards (FDA/EMA/ICH/WHO).
• Work with data management to ensure timely data transfer.
• Conduct noncompartmental analyses, population PK/PD modeling, and exposure–response analyses.
• Assess immunogenicity impact on PK/PD/safety/efficacy.
• Communicate actionable recommendations to teams and governance bodies.
• Author and review regulatory content and publication materials.
• Manage critical project deadlines and outsourcing of complex assays.
• Stay current on gene therapy pharmacology and departmental best practices.

Skills

NCA analysis

Population PK/PD modeling

Bioanalytical techniques

Regulatory understanding

Education

BS in pharmacology or related field

PhD/PharmD preferred

Tools

Phoenix WinNonlin

NONMEM

Monolix

R

Job description

Company Overview

Founded over a decade ago, CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene‑based medicines for serious human diseases. The Company has evolved from a pioneering research‑stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa‑cel]), the world’s first CRISPR‑based therapy, approved for eligible patients with sickle cell disease and transfusion‑dependent beta thalassemia. CRISPR Therapeutics is advancing a broad and diversified pipeline across hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine and rare diseases. The Company continues to expand its leadership in gene editing through the development of SyNTase™ editing, a novel and proprietary gene‑editing platform designed to enable precise, efficient, and scalable gene correction. To accelerate and expand its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly‑owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.

Position Summary

CRISPR Therapeutics is seeking a Clinical Pharmacology Lead to join us in developing novel gene therapies for serious diseases. This position will report into the Clinical Pharmacology Department, within Clinical Development. The successful candidate will have the opportunity to help answer the questions that shape how our medicines are dosed and developed. This hands‑on role spans clinical pharmacology strategy, dose selection, PK/PD analysis, bioanalytical assay strategy, liaising with SMEs for technical development of assays, CRO management, timely data delivery in support of clinical trials, and authoring relevant sections of publication/regulatory submissions. This position requires knowledge of GxP method qualification and GxP‑quality level method validation, and associated documentation in support of regulatory submissions. The ideal candidate will demonstrate enthusiasm, passion, attention to detail, and a desire to create important new medicines for patients.

Responsibilities

• Serve as the clinical pharmacology lead on cross‑functional program teams, owning clinical pharmacology strategy from IND through later‑stage development.
• Drive dose selection and justification by integrating nonclinical, translational, and emerging clinical data. This includes first‑in‑human dosing, dose escalation, and dose optimization.
• Design PK, PD, and biomarker sampling strategies for clinical protocols in partnership with clinical development, bioanalytical, and clinical operations colleagues.
• Collaborate with clinical operations and clinical sample operations to inform domestic and international sample journey plans and contribute to appropriate clinical laboratory manuals.
• Translate the needs of the clinical program into a portfolio of clinical assays and vendor strategies via collaboration with discovery/pre‑clinical scientists, clinical scientists and commercial vendors.
• Select and manage CROs and vendors supporting clinical pharmacology work, including assay development, transfer, validation, and clinical sample analysis, ensuring quality and adherence to timelines.
• Monitor GLP/GCLP quality level method validation of assays at CROs by providing technical expertise and troubleshooting, as needed, and review of documents for multiple clinical projects simultaneously.
• Ensure that assay validation and sample analyses are conducted in line with the appropriate quality and regulatory standards and guidelines (e.g., FDA, EMA, ICH, WHO, GLP/GCLP, and ISO).
• Work with clinical data management and biometrics to ensure appropriate and timely transfer of data.
• Conduct noncompartmental analyses, population PK/PD modeling, and exposure–response modeling.
• Assess the clinical impact of immunogenicity on PK, PD, safety, and efficacy.
• Interpret clinical pharmacology data and communicate it to program teams and governance bodies as clear, actionable recommendations.
• Author and review clinical pharmacology content for publications, public disclosures, and regulatory documents (e.g., INDs/CTAs, investigator’s brochures, briefing documents, clinical study reports, and BLA/MAA modules), as well as supporting reports and plans such as method development/validation reports, sample analysis reports, and SAPs.
• Manage critical project and program deadlines.
• Stay current on regulatory guidance and the science of cell and gene therapy clinical pharmacology, and contribute to departmental best practices.
• Maintain a high level of scientific, regulatory, and industry knowledge required to make science‑driven, high‑quality decisions across the outsourcing of more complex assays.

Minimum Qualifications

• BS in pharmacology, pharmaceutical sciences, pharmacometrics, biomedical engineering, or a related field, with 10+ years of industry clinical pharmacology experience.
• Hands‑on proficiency with NCA (e.g., Phoenix WinNonlin) and population modeling approaches (e.g., NONMEM, Monolix, R).
• Working knowledge of bioanalytical techniques, assay development and validation.
• Working knowledge of the principles of clinical trial operations.
• Prior experience working in a biotechnology or pharmaceutical company coordinating and managing external projects at CROs.
• Excellent oral and written communication skills.
• Ability to work independently and collaboratively in a fast‑paced, cross‑functional, results‑oriented team environment.
• Ability to work within tight timelines for successful and timely execution of project and program goals.
• Financial management of projects.
• Ability to travel, if required (Approximately 10%).

Preferred Qualifications

• PhD, PharmD, or equivalent in pharmacology, pharmaceutical sciences, pharmacometrics, biomedical engineering, or a related field, with 6+ years of industry clinical pharmacology experience.
• Working knowledge of assay development and validation across molecular (e.g., qPCR, NGS), protein (e.g., ELISA, MSD, Luminex, HPLC), and immunological (e.g., multiparameter flow cytometry, immunohistochemistry) platforms.
• Experience working in gene therapies.
• Experience contributing to a BLA or MAA submission.
• Familiarity with biomarker and immunogenicity strategy.

Competencies

• Collaborative – Openness.
• One Team Undaunted – Fearless, Can‑do attitude.
• Results Orientation – Delivering progress toward our mission.
• Sense of urgency in solving problems.
• Entrepreneurial Spirit – Proactive.
• Ownership mindset.

CRISPR Therapeutics believes in fostering a dynamic workplace that balances remote work flexibility with the benefits of in‑person interactions. Our employees work at least three days on‑site, creating a collaborative work environment, where we cultivate mentorship opportunities, increase cross‑functional communication and offer opportunities for our employees to connect. Certain lab based and manufacturing positions are located fully on‑site.

Senior Manager: Base pay range of $135,000 to $150,000+ bonus, equity and benefits The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job‑related and non‑discriminatory factors such as experience, training, skills, and abilities.

CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non‑discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.

To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy

Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research‑stage company advancing programs in the field of gene editing, to a company with a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular and rare diseases. The Nobel Prize‑winning CRISPR science has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Vertex Pharmaceuticals.

CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly‑owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom.

CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non‑discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy